Amyloid biomarkers in Alzheimer's disease

Keywords

DiseaseNeurodegenerationMedicineBiomarkerPathogenesisDementiaPittsburgh compound BAmyloid (mycology)Drug developmentAlzheimer's diseasePositron emission tomographyBioinformaticsDrugPathologyNeurosciencePharmacologyPsychologyBiologyNuclear medicine

Affiliated Institutions

Related Publications

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ <sub>42</sub> in humans

Anne M. Fagan , Mark A. Mintun , Robert H. Mach +10 more

Abstract Objectives Amyloid‐β 42 (Aβ 42 ) appears central to Alzheimer's disease (AD) pathogenesis and is a major component of amyloid plaques. Mean cerebrospinal fluid (CSF) Aβ...

2005 Annals of Neurology 1238 citations

Positron emission tomography and magnetic resonance imaging in the diagnosis and prediction of dementia

William J. Jagust

Abstract Background The diagnosis of dementia, along with the prediction of who will develop dementia, has been assisted by the development of the brain imaging techniques of ma...

2006 Alzheimer s & Dementia 72 citations

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

Clifford R. Jack , Val J. Lowe , Matthew L. Senjem +8 more

To date, most diagnostic imaging comparisons between amyloid labelling ligands and other imaging modalities have been between the use of amyloid labelling ligand (11)C Pittsburg...

2008 Brain 944 citations

Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory

Randy L. Buckner , Abraham Z. Snyder , Benjamin J. Shannon +8 more

Alzheimer's disease (AD) and antecedent factors associated with AD were explored using amyloid imaging and unbiased measures of longitudinal atrophy in combination with reanalys...

2005 Journal of Neuroscience 2114 citations

Neuropathology of synuclein aggregates

John E. Duda , Virginia M.‐Y. Lee , John Q. Trojanowski

Beginning with the isolation of the fragment of alpha-synuclein (alpha-syn) known as the non-Abeta component of amyloid plaques (NAC peptide) from Alzheimer's disease (AD) brain...

2000 Journal of Neuroscience Research 263 citations

Publication Info

Year: 2015
Type: review
Volume: 36
Issue: 5
Pages: 297-309
Citations: 466
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Amyloid biomarkers in Alzheimer's disease

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

466

OpenAlex

Cite This

APA Style

                            
                                
                                    Kaj Blennow, 
                                
                                    Niklas Mattsson, 
                                
                                    Michael Schöll
                                
                                et al.
                            
                            (2015). 
                            Amyloid biomarkers in Alzheimer's disease. 
                            Trends in Pharmacological Sciences
                            , 36
                            (5)
                            , 297-309.
                            https://doi.org/10.1016/j.tips.2015.03.002
                        

Identifiers

DOI: 10.1016/j.tips.2015.03.002